Once again this “fly on the wall” must be deaf and can’t read lips cause anything said from the “fly” has never come to light as even been remotely close to the truth.
We will be "staying tuned" forever because companies in buyout discussions or transactions do not discuss pricing and terms. Your Fly On The Wall musings are bogus.
You’re losing money and sleep like everyone else on this board with no clue when the bottom hits.
Appreciate your enthusiasm here. Hopefully JNJ earnings on 17th can stop the bleeding if imelestat on their pipeline list which it should be. They stopped other major projects to focus on this wonder drug